HC Wainwright Cuts BioNTech (NASDAQ:BNTX) Price Target to $130.00
BioNTech (NASDAQ:BNTX – Free Report) had its price target decreased by HC Wainwright from $140.00 to $130.00 in a report published on Tuesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for BioNTech’s Q1 2026 earnings at ($2.41) EPS, Q2 2026 earnings at ($2.43) EPS, Q3 […]
3 Apr 07:37 · The Markets Daily